Newstral
Warren Huff
- Plano’s Reata Pharmaceuticals strikes a $7.3 billion deal with biotech giant BiogenDallas News
- Reata stock soars on FDA approval for ultra-rare disease drug after 15 yearsDallas News
- MFDA approves Reata's rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments3 min readmarketwatch.com
- IHere’s why Reata Pharmaceuticals gained 20% on Wednesdayinvezz.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.